CreditRiskMonitor is a financial risk analysis and news service for credit, supply chain and financial professionals.  Our strength in coverage spans 58,000 global public companies, totaling about $70 trillion in corporate revenue.  We also offer solutions that can help ease private company financial risk assessment.  Leading corporations around the world – including more than 35% of the Fortune 1000, plus thousands more worldwide – rely on us to help them stay ahead of financial risk quickly, accurately and cost-effectively. 

A partial report preview for Fortrea Holdings Inc is shown below.  Where indicated by "Yes," CreditRiskMonitor contains this information in its extensive database.  To get access to the full report and learn more about CreditRiskMonitor's robust financial risk analysis and timely news service, request a personalized demo and free trial today.

If you are already a subscriber and want to access the full report, click here.

Fortrea Holdings Inc
8 Moore Drive
DURHAM, NC  27709  United States Ticker: FTREFTRE
Business Summary
Fortrea Holdings Inc. is a global contract research organization (CRO), which provides clinical development solutions to the life sciences industry. The Company is engaged in providing biopharmaceutical product and medical device development services to pharmaceutical, biotechnology and medical device customers. The Company offers customers flexible delivery models that include full service, functional service provider, and hybrid service structures. It provides phase I-IV clinical trial management, clinical pharmacology and consulting services. The Company manages its business through a single segment, Clinical Services, that provides services across the clinical pharmacology and clinical development spectrum. The Company has access to all key markets worldwide through a footprint of primary office locations in five countries (the United States, the United Kingdom, China, India and Singapore) with field operations in other jurisdictions worldwide.

Scores and Ratings
FRISK®
Score		 Z''
Score		 PAYCE®
Score		 DBT
Index		 Moody's
Rating		 Fitch
Rating		 DBRS
Rating
YesYes-YesYes--

Financials, News and Filings
Latest
Statement		 Last
Audit
News		 SEC
Filings		 Bankruptcy
Filings		 Suit &
Judgment
Filings		 Tax
Lien
Filings
9/30/202412/31/2023YesYes--Yes

Industries
SIC Code Description
8731 Commercial physical and biological research

Officers and Directors

Title
Name
Age		 Title
Date		 Start
Date
Chairman of the Board, Chief Executive Officer Thomas H.Pike 64 6/29/2023 6/29/2023
Chief Financial Officer JillMcconnell 50 6/29/2023 6/29/2023
Chief Operating Officer President - Clinical Services MarkMorais 48 6/29/2024 6/29/2024
5 additional Officers and Directors records available in full report.

Subsidiaries
Business Name Address City State/Province Country
Chiltern International Limited 171 Bath Road Berkshire United Kingdom
Labcorp Early Development Services GmbH Kesselfeld 29 Munster Germany
The National Food Laboratory 365 North Canyons Parkway Livermore CA United States
3 additional Subsidiary records available in full report.

Business Names
Business Name
Active Entities
Chiltern Clinical Research (Philippines) Inc.
Chiltern International AB
112 additional Business Names available in full report.

General Information
Number of Employees: 15,500 (As of 9/30/2024)
Outstanding Shares: 89,700,000 (As of 11/6/2024)
Shareholders: 1,748
Stock Exchange: NASD
Federal Tax Id: 922796441
Fax Number: (302) 636-5454


Copyright © 2024 CreditRiskMonitor.com (Ticker: CRMZ). All rights reserved.     
By using this website, you accept the Terms of Use Agreement.
Wednesday, November 20, 2024